Dr Reddy's just got the thumbs up to sell a generic version of Ozempic, the diabetes champ! They're gearing up to launch 12 million Semaglutide pens this year, with their eyes on the weight-loss prize when the patent runs out in 2026. Even with a profit dip, their India revenue is up 19%, so things are looking bright!

Health

